Jinming Song is board-certified in anatomic pathology,
surgical pathology, and hematopathology. His specialty is the diagnosis of
acute and chronic leukemia, lymphoma, and other benign or malignant
hematopoietic disorders. His expertise includes evaluation and interpretation
of peripheral blood smears, bone marrow biopsies, lymphoid and non-lymphoid
tissues, flow cytometry, molecular pathology, especially NextGen sequencing,
and cytogenetics. His research interests are in personalized medicine, the use of
gene mutations and cytogenetic abnormalities for the diagnosis, and the
prediction of prognosis and treatment responses in patients with hematopoietic
disorders. His interests also include the identification of alternative
indications for late-stage compounds or drugs.
Research Keywords & Expertise
NextGen
mutations
Myeloid neoplasm
Myeloproliferative
Myelodysplastic
Fingerprints
27%
mutations
8%
Myeloid neoplasm
5%
NextGen
5%
Myeloproliferative
5%
Myelodysplastic
Short Biography
Jinming Song is board-certified in anatomic pathology,
surgical pathology, and hematopathology. His specialty is the diagnosis of
acute and chronic leukemia, lymphoma, and other benign or malignant
hematopoietic disorders. His expertise includes evaluation and interpretation
of peripheral blood smears, bone marrow biopsies, lymphoid and non-lymphoid
tissues, flow cytometry, molecular pathology, especially NextGen sequencing,
and cytogenetics. His research interests are in personalized medicine, the use of
gene mutations and cytogenetic abnormalities for the diagnosis, and the
prediction of prognosis and treatment responses in patients with hematopoietic
disorders. His interests also include the identification of alternative
indications for late-stage compounds or drugs.
Advance your academic career, collaborate globally, and expand your network—
join now
!
Well done!
